Nucala 100 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FDL86
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $189,290
Award facts
- Contract value 100% obligated
- $189,290.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $189,290 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nucala 100 mg/mL syringes. This firm fixed-price delivery order, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, was awarded without set-aside designation. The contract falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products, biologics, and medical consumables to support military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing delivery orders from DLA for specialized medical products ranging from prescription medications to oncology treatments and vaccines. The company's performance under the IDC vehicle demonstrates DLA's reliance on DMS Pharmaceutical Group's distribution capabilities to fulfill the Department of Defense's pharmaceutical needs. As a woman-owned small business registered in SAM.gov since 2001, the company competes effectively in federal procurement markets while maintaining a robust portfolio of branded and generic pharmaceutical products serving military and federal healthcare systems nationwide.
Quick answers
Who was awarded contract SPE2DB25FDL86?
SPE2DB25FDL86 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FDL86 worth?
The government has obligated $189,290 on SPE2DB25FDL86.
Is contract SPE2DB25FDL86 an order under another contract?
Yes. SPE2DB25FDL86 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL86 competed?
The extent of competition for SPE2DB25FDL86 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award